Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer

Nature Genetics
K HovanesM L Waterman

Abstract

Constitutive activation of the Wnt signaling pathway is a root cause of many colon cancers. Activation of this pathway is caused by genetic mutations that stabilize the beta-catenin protein, allowing it to accumulate in the nucleus and form complexes with any member of the lymphoid enhancer factor (LEF1) and T-cell factor (TCF1, TCF3, TCF4) family of transcription factors (referred to collectively as LEF/TCFs) to activate transcription of target genes. Target genes such as MYC, CCND1, MMP7 and TCF7 (refs. 5-9) are normally expressed in colon tissue, so it has been proposed that abnormal expression levels or patterns imposed by beta-catenin/TCF complexes have a role in tumor progression. We report here that LEF1 is a new type of target gene ectopically activated in colon cancer. The pattern of this ectopic expression is unusual because it derives from selective activation of a promoter for a full-length LEF1 isoform that binds beta-catenin, but not a second, intronic promoter that drives expression of a dominant-negative isoform. beta-catenin/TCF complexes can activate the promoter for full-length LEF1, indicating that in cancer high levels of these complexes misregulate transcription to favor a positive feedback loop for Wnt si...Continue Reading

References

Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Sep 4, 1998·Science·T C HeK W Kinzler
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·M AokiP K Vogt
Oct 9, 1999·The American Journal of Pathology·T BrabletzT Kirchner
Mar 10, 2000·Advances in Experimental Medicine and Biology·P PolakisB Rubinfeld

❮ Previous
Next ❯

Citations

May 15, 2002·Genes, Chromosomes & Cancer·Karen M Hajra, Eric R Fearon
Sep 5, 2002·Journal of Surgical Oncology·Holly L NeibergsJohn S Spratt
Jul 5, 2007·Science in China. Series C, Life Sciences·Jing ZhangYanDa Li
Jun 5, 2003·Biochimica Et Biophysica Acta·Rachel H GilesHans Clevers
Jun 16, 2009·Nature Medicine·Luca GattinoniNicholas P Restifo
Oct 3, 2002·Nature Reviews. Cancer·James E Darnell
Jan 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kevin J Wright, Robert Tjian
Sep 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Pradeep S TanwarJose M Teixeira
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Melinda L Angus-HillMario R Capecchi
Nov 24, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kristine GermarFotini Gounari
Oct 22, 2009·The Journal of Biological Chemistry·Guido T BommerEric R Fearon
Jan 29, 2011·The Journal of Biological Chemistry·Luke H HoeppnerJennifer J Westendorf
Nov 11, 2008·The Journal of Biological Chemistry·Masaaki NakayamaToshiya Hirayama
Dec 20, 2011·Carcinogenesis·Charles GiardinaDaniel W Rosenberg
Dec 27, 2011·Carcinogenesis·Rohinton S TaraporeHasan Mukhtar
May 15, 2002·The EMBO Journal·Adam Hurlstone, Hans Clevers
Jul 16, 2009·Human Molecular Genetics·Ludmila Prokunina-OlssonJennifer L Hall
Jun 19, 2003·Journal of the National Cancer Institute·Takashi KumagaiH Phillip Koeffler
Oct 28, 2006·Nucleic Acids Research·Evan DiamondBrad A Amendt
Jun 8, 2010·Nucleic Acids Research·Noriko N YokoyamaMarian L Waterman
Sep 17, 2010·Nucleic Acids Research·Hao SunRamana V Davuluri
Oct 13, 2006·Current Opinion in Gastroenterology·Marian L Waterman
Jun 18, 2005·Genes & Development·William E LowryElaine Fuchs
Jul 1, 2006·Molecular and Cellular Biology·Tony W-H LiMarian L Waterman
Apr 18, 2007·Molecular and Cellular Biology·Shu ZhangKeith A Wharton
Sep 6, 2007·Molecular and Cellular Biology·Melanie AmenBrad A Amendt
Aug 9, 2006·Molecular and Cellular Biology·Laura PereiraBradley J Merrill
Sep 26, 2007·Molecular and Cellular Biology·Fawzia A AtchaMarian L Waterman
Jul 11, 2012·Molecular and Cellular Biology·Nate P HoverterMarian L Waterman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.